US3304238A - Enzymic material and method of preparing same - Google Patents

Enzymic material and method of preparing same Download PDF

Info

Publication number
US3304238A
US3304238A US492875A US49287565A US3304238A US 3304238 A US3304238 A US 3304238A US 492875 A US492875 A US 492875A US 49287565 A US49287565 A US 49287565A US 3304238 A US3304238 A US 3304238A
Authority
US
United States
Prior art keywords
seed
rna
water
parts
enzymic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US492875A
Other languages
English (en)
Inventor
Laufer Louis
Gutcho Sidney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHWARZ BIO RES Inc
SCHWARZ BIO RESEARCH Inc
Original Assignee
SCHWARZ BIO RES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US313433A external-priority patent/US3303100A/en
Priority to FR987735A priority Critical patent/FR1438228A/fr
Priority to BE653073D priority patent/BE653073A/xx
Priority to NL6410733A priority patent/NL6410733A/xx
Priority to DE19641470320 priority patent/DE1470320A1/de
Priority to GB40427/64A priority patent/GB1026639A/en
Application filed by SCHWARZ BIO RES Inc filed Critical SCHWARZ BIO RES Inc
Priority to US492875A priority patent/US3304238A/en
Application granted granted Critical
Publication of US3304238A publication Critical patent/US3304238A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Definitions

  • RNA should be understood to mean ribonucleic acid.
  • RNA derivatives refers to ribonucleosides and ribonucleotides as well as compounds which are deriva tives or homologues of these sub-units of RNA.
  • a ribonucleoside is an N-glycoside of a heterocyclic base, generally a pyrimidine or purine.
  • a ribonucleotide is a phosphoric acid ester of a ribonucleoside and may be ribonucleoside monophosphate or a ribonucleoside polyphoshate.
  • RNA polymers found primarily in the cytoplasmic portions of cells, in various degrees of polymerization, are connected with the synthesis of specific proteins required by the cells.
  • Monomeric nucleotides of RNA are found within cells in combination especially with many of the B vitamins, in which form they function as coenzymes promoting specific reactions necessary for the normal function of the organism.
  • R may be a purine or pyrimidine base, most commonly in nature; adenine, guanine, uracil, or cytosine.
  • the vertical heavy line represents a five-carbon sugar in pyranose configuration (d-ribose) and the numbers 3 and 5 represent respectively the third and fifth carbon of this sugar.
  • P is a phosphate ester bridge connecting adjacent monomers through a linkage between the 3 and 5' carbons.
  • the polymer schematically shown may be degraded in many ways by a variety of enzymes which have been isolated from mammalian tissue, snake venom, and other living cells such as micro-organisms, at an extremely high cost.
  • the procedure is thought to be usually stepwise with certain alternative pathways.
  • the enzyme with activity responsible for reducing the size of N is called a nuclease or depolymerase. Once this shortening is acice complished the phosphate bridges can be attacked specifically either at points indicated by the dotted lines, or at the wavy lines.
  • RNA degradation products Many of the degradation products outlined above have become significant articles of commerce because of their importance in research studies on the chemistry and properties of RNA. .They are also used in pharmaceutical preparations. Also, the 5-ribonucleotides (particularly inosine 5-monoph0sphate (IMP) and guanosine 5-monophosphate (GMP)) have become important as food flavoring enhancers.
  • IMP inosine 5-monoph0sphate
  • GMP guanosine 5-monophosphate
  • the rapidly proliferating parts (the rootlets and stems) of germinating seeds surprisingly constitute a particularly rich source of enzymes which are capable of readily splitting RNA.
  • enzymes may be simply and efliciently utilized for such splitting of RNA, particularly for the production of 5-nucleotides.
  • the proliferating rootlets of the seeds are the richest source of enzymic material, the stems containing less, but useful quantities, whereas the seed or kernel itself does not contain a commercially attractive quantity.
  • the property of the proliferating parts of the seed as a rich source of enzymic material is general property of seeds as a class and is particularly true of monocotyledon seeds.
  • Preferable seeds are: those capable of being malted, such as oats, barley, wheat, corn, rye, mullet, sorghums, and
  • bean seeds are germinated for the production of bean sprouts, making available a cheap and plentiful supply of these rootlets for the practice of the invention.
  • malt sprouts commercially known as malt sprouts
  • any readily available seed rootlet or sprout can be substituted, such as, for example, those from wheat malt, rice malt, or rye malt, or bean shoots, or any of those mentioned above.
  • the uncomminuted rapidly proliferating parts of germinating seeds are initially treated to obtain an enzymic medium which is capable of hydrolyzing RNA to provide the desired high yields of nucleotides.
  • the seed-parts which are normally dry, are first either: soaked in water and then washed with a further quantity of water; or subjected to a multiplicity of washings with water. Where the initial treatment of seed-parts comprises soaking followed by washing, the soaking period should extend for from about 30 to 90 minutes to precondition and hydrate the seedparts. The soaked seed-parts are thereafter washed with water to remove bacteria.
  • the washing treatment is particularly important where the seed-parts comprise malted rootlets since such rootlets contain bacteria (resulting from the malting process) which, if not removed, proliterate enzymes destructive to 5-nucleotides.
  • the washing may be continuous with the waste water continuously removed or may be accomplished as a series of batch washings with the waste water removed after each wash period.
  • the water utilized for soaking the seed-parts and/or washing the seed-parts should not be extremely hard, i.e., contain more than about 1000 parts per million of hardness. Where the natural sources of water yield only hard water, the final washing of seed-parts should be preferably carried out using deionized or soft" water.
  • the soaking stage may be eliminated provided the washing period is sufficient to accomplish the desired hydration and preconditioning action.
  • small quantities of a suitable bactericide may be added to the wash water utilized during one or more of thewashings.
  • seed-parts After suflicient washing, additional water is mixed with the washed seed-parts in a preferred ratio of about 5 to 15 parts by weight of water to one part by weight of solids (seed-parts). Where the seed-parts comprise malt sprouts, the ratio of water to solids may be preferably about to 1. a
  • the water/seed-part suspension or slurry is next sub jected to a relatively short heat treatment (about 0.5 to about 7 minutes and preferably 2 to 5 minutes) during which such suspension is agitated.
  • a relatively short heat treatment about 0.5 to about 7 minutes and preferably 2 to 5 minutes
  • steam may be directly introduced into the suspension in sufficient amount and for a sufficient time to rapidly establish and maintain the temperature of the suspension at between 70 to 85 C. and preferably 70 to 75 C. with optimum commercial results being achieved at about 72 C.
  • phosphatase deactivators or inhibitors Prior to the heating period, and while maintaining agitation of the suspension, phosphatase deactivators or inhibitors are added to the solution.
  • Such deactivators may comprise: metallic ions (zinc), preferably ZnAc -H O, as a deactivator of 5-ribonucleotidase; and borate ions (such as H BO which may act as a deactivator of general phosphatases.
  • metallic ions preferably ZnAc -H O
  • borate ions such as H BO which may act as a deactivator of general phosphatases.
  • Enzymic media prepared as described heretofore, have a broad spectrum of activity with respect to ribonucleic acid but, in accordance with the further embodiments of this invention, it has been discovered that by careful control of such activity a surprisingly high yield of 5'- nucleotides may be obtained by hydrolyzing such acid with such media in a relatively short time period.
  • 5'-nucleotides may be selectively obtained from RNA by the reaction of a digestion solution of RNA and enzyme material heated to from about 60 to 70 C. for from about 1% to about 5 /2 hours.
  • the initial pH of the RNA solution may be as high as 8.5 and preferably the pH of the digestion solution does not decrease during hydrolysis to below about 5.2.
  • RNA hydrolysis it is important that the seed-parts remain substantially in particulate form during the heat treatment stage and during the subsequent RNA hydrolysis stage.
  • a heat treated enzyme medium comprised of water and the rapidly proliferating parts of germinating seeds wherein the seed-parts are not comminuted and remain as particulate matter in the medium.
  • Improved enzymic medium to RNA solution ratios are possible. Radically shorter hydrolysis times are required.
  • Significantly simplified solids separation procedures are required and there are less non-enzymatic impurities extracted into the hydrolyzate mixture.
  • overall processing of the enzymic medium and hydrolyzate mixture is possible together with the attainment of exceptionally high yields of 5'-mononucleotides in the final hydrolyzed solution.
  • a ribonucleic acid solution is introduced to a hydrolysis stage together with the enzymic medium (includes seed-parts) from the heat treating stage to form a digestion or hydrolysis solution including suspended seed-parts.
  • the nucleic acid solution may comprise RNA, water, and appropriate amount of an alkaline material for adjusting the pH of such solution to the preferred alkaline range. Any of the well-known alkaline pH adjusting materials may be used such as: ammonium hydroxide and ammonium carbonate; sodium hydroxide; tris (hydroxy methyl) amino methane; and primary, secondary and tertiary amines which are water miscible.
  • the digestion or hydrolysis solution (enzymic medium including seedparts-l-RNA solution including pH adjustment agent) a may comprise about 24% RNA with the ratio of enzymic medium to RNA solution being from about 1:1 to about 3:1.
  • the final digest solution which may have its pH range adjusted periodically (if necessary) to maintain the same within the range of 5.2 to 8.5, is heated to from about 60 to about 70 C. (preferably 63 to 67 tides.
  • RNA .--150 liters of RNA solution (30 kg. of commercial RNA and 500 g. NaF) at pH 7.0-7.1 (adjusted with NaOH) and at 20 C. was added rapidly to the above pretreated water/seed-part suspension with the total mixture agitated and the temperature adjusted to about 65 C. Agitation was continued and the temperature maintained at between 64.5" C. and 65.5 C. for 2 hours. Analysis of the hydrolysis solution indicated nucleic :acid degradation to be 95% with 90% 5'-nucleotides present. The hydrolysis was stopped by lowering the temperature of the mixture to 35 C. and adjustiiig the pH to 3.43.6 by the addition of HCl. was filtered to remove the spent plant parts with the filtrate further treated to obtain the desired 5'-nucleotides free of impurities.
  • EXAMPLE 11 A further series of experiments was carried out to determine additional processing conditions.
  • Experiments p throungh set forth in table on next page, relate to processing wherein uniform lots of dried seed-parts (same malt sprouts and quantities as in Example 10) were: (1) subject to five washings each with water; (2) mixed with water in a ratio of 1.0 kg. of sprouts to 10.0 liters of water; and (3) heat treated as indicated in the table.
  • the resulting enzyrnic medium (including malt sprouts) in each instance was then: (1) mixed with a 9.0% RNA solution in a ratio of 2.2 kg. of dried sprouts to 1.0 kg. of commercial RNA (about 90%); and (2) hydrolyzed under varying temperatures and RNA solu- TABLE V Heat Treatment Hydrolyzate Analysis Experi- Hydrolysis,
  • Mung Bean Sprouts 1 1 was ground in a Waring Blendor. Both parts were mixed with equal proportions of water with zinc ion added and heat treated at 72 C. for five minutes. The quantities of water and seed-parts were the same as used during the foregoing experiments involving malt sprouts. Both enzymic media (ground grain and unground grains) were mixed with RNA solution at pH 7.0. The final RNA concentration of both mixtures was 3%. NaF was added 2.
  • the aqueous enzymic medium claimed in claim 1 in which the rapidly proliferating seed-parts are derived from seeds selected from the group consisting of oats, barley, Wheat, corn, rye, rice, grass, bean, pea, melon, papaya, locust bean, sunflower and sesame seeds.
  • impurities which may hamper subsequent separation of the 5'- nucleotides are removed.
  • impurities are mainly (I) inorganic phosphates, (2) protein from the enzymic medium, (3) small amounts of unhydrolyzed nucleic acid, and (4) nucleosides.
  • the first three can be removed by at least two methods.
  • One method involves the addition of barium hydroxide to pH of 9.0.
  • the barium hydroxide addition stops enzyme action immediately and causes precipitation of impurities which can be removed from the 5'-nucleotide solution by filtration. This method may result in the removal of small amounts of the desired 5'-nucleotides, particularly purine nucleotides.
  • a second method of removing impurities involves the addition to the hydrolysis solution of alcohol to stop enzyme action and precipitate protein and some sodium phosphate. Small amounts of purine nucleotides are also precipitated. The precipitate is filtered off and the filtrate used to separate 5-nuc1eotides.
  • the filtrate (after removal of impuri ties) contains nucleotides which may be separated by well-known ion-exchange techniques.
  • an enzymic media comprised of water and uncomminuted seed-parts (which has been heat treated in a manner similar to that described herein before) may be utilized to degrade or digest deoxyribonucleic acid to form 5'-deoxyribonucleotides.
  • An aqueous enzymic medium capable of digesting ribonucleic acid to form primarily 5'-ribonucleotides comprising a dispersion of discrete rapidly proliferating substantially non-comminuted seed-parts selected from the group consisting of substantially seed-free germinating seed rootlets and substantially seed-free germinating seed stems in water, said mixture having been heated to from between about 70 to about 85 C..for from about 0.5 to about 7 minutes.
  • a method for the preparation of an aqueous enzymic medium capable of digesting ribonucleic acid to form primarily 5-ribonucleotides which comprises:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Cereal-Derived Products (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
US492875A 1963-10-03 1965-10-04 Enzymic material and method of preparing same Expired - Lifetime US3304238A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR987735A FR1438228A (fr) 1963-10-03 1964-09-10 Digestion enzymatique d'acide nucléique
BE653073D BE653073A (fr) 1963-10-03 1964-09-14
NL6410733A NL6410733A (fr) 1963-10-03 1964-09-15
DE19641470320 DE1470320A1 (de) 1963-10-03 1964-09-29 Verfahren zum enzymatischen Abbau von Nucleinsaeuren
GB40427/64A GB1026639A (en) 1963-10-03 1964-10-05 Preparation of enzymic material and enzymic digestion of nucleic acid
US492875A US3304238A (en) 1963-10-03 1965-10-04 Enzymic material and method of preparing same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US313433A US3303100A (en) 1963-10-03 1963-10-03 Enzyme digestion of nucleic acid
US492875A US3304238A (en) 1963-10-03 1965-10-04 Enzymic material and method of preparing same

Publications (1)

Publication Number Publication Date
US3304238A true US3304238A (en) 1967-02-14

Family

ID=26978868

Family Applications (1)

Application Number Title Priority Date Filing Date
US492875A Expired - Lifetime US3304238A (en) 1963-10-03 1965-10-04 Enzymic material and method of preparing same

Country Status (6)

Country Link
US (1) US3304238A (fr)
BE (1) BE653073A (fr)
DE (1) DE1470320A1 (fr)
FR (1) FR1438228A (fr)
GB (1) GB1026639A (fr)
NL (1) NL6410733A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009276A1 (fr) * 1988-03-25 1989-10-05 Enzyme Bio-Systems Ltd. Preparation de 5'-phosphodiesterase et son procede de production
US5034325A (en) * 1988-03-25 1991-07-23 Enzyme Bio-Systems, Ltd. 5'-phosphodiesterase enzyme preparation and method for its production
US20040082776A1 (en) * 2002-09-03 2004-04-29 Matthias Busse Process for recovery of uridine from molasses
US20090324778A1 (en) * 2006-09-12 2009-12-31 Lesaffre Et Compagnie Novel preparation of phosphodiesterase of plant origin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE529218A (fr) * 1966-03-18

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3120511A (en) * 1961-09-21 1964-02-04 Takeda Chemical Industries Ltd Production of a mixture of sodium salts of 5'-inosinic acid and 5'-guanylic acid
US3163586A (en) * 1960-12-13 1964-12-29 Takeda Chemical Industries Ltd Method for preparing 5'-nucleotides
US3168446A (en) * 1958-03-21 1965-02-02 Takeda Pharmaceutical Production of 5'-nucleotides and of nucleosides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168446A (en) * 1958-03-21 1965-02-02 Takeda Pharmaceutical Production of 5'-nucleotides and of nucleosides
US3163586A (en) * 1960-12-13 1964-12-29 Takeda Chemical Industries Ltd Method for preparing 5'-nucleotides
US3120511A (en) * 1961-09-21 1964-02-04 Takeda Chemical Industries Ltd Production of a mixture of sodium salts of 5'-inosinic acid and 5'-guanylic acid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009276A1 (fr) * 1988-03-25 1989-10-05 Enzyme Bio-Systems Ltd. Preparation de 5'-phosphodiesterase et son procede de production
US5034325A (en) * 1988-03-25 1991-07-23 Enzyme Bio-Systems, Ltd. 5'-phosphodiesterase enzyme preparation and method for its production
US20040082776A1 (en) * 2002-09-03 2004-04-29 Matthias Busse Process for recovery of uridine from molasses
US20090324778A1 (en) * 2006-09-12 2009-12-31 Lesaffre Et Compagnie Novel preparation of phosphodiesterase of plant origin

Also Published As

Publication number Publication date
GB1026639A (en) 1966-04-20
BE653073A (fr) 1964-12-31
FR1438228A (fr) 1966-05-13
DE1470320A1 (de) 1969-05-29
NL6410733A (fr) 1965-04-05

Similar Documents

Publication Publication Date Title
Wackeb Molecular mechanisms of radiation effects
US5859333A (en) Plants and processes for obtaining them
CN105431534A (zh) β-1,3-葡聚糖酶、多核苷酸、重组载体、转化体、β-1,3-葡聚糖酶的制造方法、酶制剂及低分子化裸藻淀粉的制造方法
Spiegelman et al. Some basic problems in the relation of nucleic acid turnover to protein synthesis
Bresnick Feedback inhibition of aspartate transcarbamylase in liver and in hepatoma
US3304238A (en) Enzymic material and method of preparing same
US3459637A (en) Enzyme digestion of nucleic acids
Schimpff et al. Age-dependent DNA labeling and deoxyribonucleotide synthesis in wheat seeds
US3303100A (en) Enzyme digestion of nucleic acid
JPH05176757A (ja) 酵母菌体の製造方法
Prentice Characterization of a nuclease from malted barley roots
US3616234A (en) Method of preparing protease from candida lipolytica
US5034325A (en) 5'-phosphodiesterase enzyme preparation and method for its production
AU625555B2 (en) 5'-phosphodiesterase enzyme preparation and method for its production
TERAO et al. Purification and properties of phosphodiesterase from bovine pancreas
JP3014950B2 (ja) トレハロースの製造方法
JP3040976B2 (ja) トレハロースを含有する糖化液の製造方法
JPH02242654A (ja) 酵母エキス製造法
CA1077772A (fr) Methode pour la recuperation dans les microorganismes de proteines a faible teneur en acide nucleique
JPH05236954A (ja) 耐熱性アデノシン−5’−ホスホスルフェートキナーゼ及びその製造法
JPH0998779A (ja) トレハロース合成酵素、その製法及びそれを用いたトレハロースの製造法
JPH01153693A (ja) 大豆オリゴ糖の改質法
SU1100308A1 (ru) Способ получени кислой дезоксирибонуклеазы
SU1053832A1 (ru) Способ получени 5-дезоксирибомононуклеотидов
Lee et al. Deoxyribonuclease from the intestinal mucosa of the rat